Opus Genetics Inc
(IRD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,303 | -4,304 | -3,407 | -2,368 | -1,184 |
| Depreciation Amortization | -1 | -10 | -10 | -6 | -2 |
| Other Working Capital | -70 | -203 | -77 | -54 | 60 |
| Other Operating Activity | 188 | 1,122 | 786 | 572 | 289 |
| Operating Cash Flow | $-1,187 | $-3,395 | $-2,708 | $-1,855 | $-838 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,398 | -3,550 | N/A | N/A | N/A |
| PPE Investments | -25 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-1,423 | $-3,550 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 900 | 6,720 | 42 | 14 | N/A |
| Financing Cash Flow | $900 | $6,720 | $42 | $14 | $N/A |
| Beginning Cash Position | 3,810 | 4,034 | 4,034 | 4,034 | 4,034 |
| End Cash Position | 2,100 | 3,810 | 1,368 | 2,193 | 3,196 |
| Net Cash Flow | $-1,710 | $-225 | $-2,666 | $-1,841 | $-838 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,187 | -3,395 | -2,708 | -1,855 | -838 |
| Capital Expenditure | -25 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -1,212 | -3,395 | -2,708 | -1,855 | -838 |